Description
In this issue of Immunology & Allergy Clinics, guest editor Dr. Marcus S. Shaker brings his considerable expertise to the topic of Anaphylaxis. Top experts provide updates on anaphylaxis epidemiology, guidelines, and diagnostics, as well as mast cell activation syndrome, mastocytosis, novel therapies, and more.- Contains 15 relevant, practice-oriented topics including venom anaphylaxis; anaphylaxis guidelines; equity and anaphylaxis; future anaphylaxis therapies; novel epinephrine delivery devices; preventing food anaphylaxis; and more- Provides in-depth clinical reviews on anaphylaxis, offering actionable insights for clinical practice- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews
Table of Contents
Anaphylaxis Epidemiology and Risk FactorsAnaphylaxis: Clinical Criteria, Severity, and Clinical CoursesCommunity AnaphylaxisEquity and AnaphylaxisAnaphylaxis GuidelinesPreventing Food AnaphylaxisDrug AnaphylaxisBeta-Blockers, Angiotensin-Converting Enzyme Inhibitors, and AnaphylaxisIodinated Contrast Media and AnaphylaxisVenom AnaphylaxisNovel Epinephrine Delivery DevicesEmerging Therapies for AnaphylaxisHereditary Alpha-Tryptasemia (HαT) as a Risk Modifier for Severe AnaphylaxisMast Cell Activation Syndrome and Mimickers
